Ocular Therapeutix (OCUL) Non-cash Items (2014 - 2025)
Ocular Therapeutix's quarterly Non-cash Items came in at $10.9 million in Q4 2025, down 73.89% year-on-year from $41.6 million in Q4 2024, and down 73.89% quarter-over-quarter from $41.6 million in Q4 2024.
Ocular Therapeutix has reported Non-cash Items for 12 years, with the latest figure at $10.9 million in Q4 2025.
- For the quarter ending Q4 2025, Non-cash Items fell 73.89% year-over-year to $10.9 million; the trailing twelve-month figure through Dec 2025 stood at $10.9 million (down 73.89% YoY), and the FY2025 full-year result was $10.9 million, down 4.97% from the prior year.
- Non-cash Items for Q4 2025 stood at $10.9 million, down from $41.6 million in the prior quarter.
- The five-year high for Non-cash Items was $41.6 million in Q4 2024, with the low at $7000.0 in Q4 2022.
- Average Non-cash Items over 5 years is $13.8 million, with a median of $10.9 million recorded in 2025.
- Year-over-year, Non-cash Items plunged 99.95% in 2022 and jumped 47957.14% in 2023.
- Tracing OCUL's Non-cash Items over 5 years: stood at $13.3 million in 2021, then sank by 99.95% to $7000.0 in 2022, then jumped by 47957.14% to $3.4 million in 2023, then soared by 1135.73% to $41.6 million in 2024, then slumped by 73.89% to $10.9 million in 2025.
- The last three Non-cash Items figures came in at $10.9 million (Q4 2025), $41.6 million (Q4 2024), and $3.4 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.85 Mn |
| Dec 31, 2025 | 10.85 Mn |
| Dec 31, 2024 | 41.57 Mn |
| Dec 31, 2024 | 41.57 Mn |
| Dec 31, 2023 | 3.36 Mn |
| Dec 31, 2023 | 3.36 Mn |
| Dec 31, 2022 | 7,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 13.28 Mn |
| Dec 31, 2021 | 13.28 Mn |
| Dec 31, 2020 | 16.08 Mn |
| Dec 31, 2020 | 16.08 Mn |
| Dec 31, 2019 | 704,000.00 |
| Dec 31, 2019 | 704,000.00 |
| Dec 31, 2018 | 654,000.00 |
| Dec 31, 2018 | 654,000.00 |
| Dec 31, 2017 | 1.22 Mn |
| Dec 31, 2017 | 1.22 Mn |
| Dec 31, 2016 | 6.66 Mn |
| Dec 31, 2016 | 6.66 Mn |
| Dec 31, 2015 | 5.90 Mn |
| Dec 31, 2015 | 5.90 Mn |
| Dec 31, 2014 | 29.46 Mn |
| Dec 31, 2014 | 29.46 Mn |